Kulla A - Search Results

1

Descriptive epidemiology of spinal muscular atrophy type I in Estonia.

Vaidla E, Talvik I, Kulla A, Kahre T, Hamarik M, Napa A, Metsvaht T, Piirsoo A, Talvik T. Vaidla E, et al. Among authors: kulla a. Neuroepidemiology. 2006;27(3):164-8. doi: 10.1159/000096128. Neuroepidemiology. 2006. PMID: 17035693

2

Neonatal spinal muscular atrophy type 1 with bone fractures and heart defect.

Vaidla E, Talvik I, Kulla A, Sibul H, Maasalu K, Metsvaht T, Piirsoo A, Talvik T. Vaidla E, et al. Among authors: kulla a. J Child Neurol. 2007 Jan;22(1):67-70. doi: 10.1177/0883073807299954. J Child Neurol. 2007. PMID: 17608308

3

Epidemiology of primary central nervous system tumors in Estonia.

Liigant A, Asser T, Kulla A, Kaasik AE. Liigant A, et al. Among authors: kulla a. Neuroepidemiology. 2000 Nov-Dec;19(6):300-11. doi: 10.1159/000026269. Neuroepidemiology. 2000. PMID: 11060504

4

Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas.

Kulla A, Liigant A, Piirsoo A, Rippin G, Asser T. Kulla A, et al. Mod Pathol. 2000 Jan;13(1):56-67. doi: 10.1038/modpathol.3880010. Mod Pathol. 2000. PMID: 10658911

5

Survival of patients with primary CNS tumours in Estonia.

Liigant A, Kulla A, Linnamägi U, Asser T, Kaasik AE. Liigant A, et al. Among authors: kulla a. Eur J Cancer. 2001 Oct;37(15):1895-903. doi: 10.1016/s0959-8049(01)00220-9. Eur J Cancer. 2001. PMID: 11576846

6

Odontogenic tumours, a collaborative retrospective study of 75 cases covering more than 25 years from Estonia.

Tamme T, Soots M, Kulla A, Karu K, Hanstein SM, Sokk A, Jõeste E, Leibur E. Tamme T, et al. Among authors: kulla a. J Craniomaxillofac Surg. 2004 Jun;32(3):161-5. doi: 10.1016/j.jcms.2003.12.004. J Craniomaxillofac Surg. 2004. PMID: 15113574

7

Comparative expression analysis of the genes encoding polypyrimidine tract binding protein (PTB) and its neural homologue (brPTB) in prenatal and postnatal mouse brain.

Lilleväli K, Kulla A, Ord T. Lilleväli K, et al. Among authors: kulla a. Mech Dev. 2001 Mar;101(1-2):217-20. doi: 10.1016/s0925-4773(00)00566-9. Mech Dev. 2001. PMID: 11231079 Free article.

8

Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.

Kulla A, Burkhardt K, Meyer-Puttlitz B, Teesalu T, Asser T, Wiestler OD, Becker AJ. Kulla A, et al. Acta Neuropathol. 2003 Apr;105(4):328-32. doi: 10.1007/s00401-003-0681-6. Epub 2003 Feb 14. Acta Neuropathol. 2003. PMID: 12624785

9

Tissue plasminogen activator as a key effector in neurobiology and neuropathology.

Teesalu T, Kulla A, Asser T, Koskiniemi M, Vaheri A. Teesalu T, et al. Among authors: kulla a. Biochem Soc Trans. 2002 Apr;30(2):183-9. Biochem Soc Trans. 2002. PMID: 12023848 Review.

10

Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system.

Teesalu T, Kulla A, Simisker A, Sirén V, Lawrence DA, Asser T, Vaheri A. Teesalu T, et al. Among authors: kulla a. Thromb Haemost. 2004 Aug;92(2):358-68. doi: 10.1160/TH02-12-0310. Thromb Haemost. 2004. PMID: 15269833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters